Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Mitsubishi Tanabe Pharma
 More »

  • Double Manufacturing Deals for Sanofi
    Vivus hopes this regulatory approval will be completed no later than June 30, 2015, and will be working with Mitsubishi Tanabe Pharma in the meantime as its source for avanafil ...
    8-1-2013
  • Mitsubishi Tanabe Buys Medicago for $357M
    Medicago said today it agreed to be acquired by Mitsubishi Tanabe Pharma for $357 million, creating a combined biopharma focused in part on continuing the acquired company's work ...
    7-12-2013
  • Top 20 Corporate Venture Funds
    ... such as multiple sclerosis Year established: 2001 (as Genzyme Ventures) #11. (tie) MP Healthcare Venture Management (MPH; Mitsubishi Tanabe Pharma Group) Resources: $100 million . ...
    6-14-2013
  • Biotechs Need to Walk the Walk on Drug Value
    ... Two months later, 10 pharma giants-AbbVie, AstraZeneca (AZ), Boehringer Ingelheim, ... Gilead, Glaxo, Janssen, Merck, Mitsubishi Tanabe, Novartis, Pfizer, and Sanofi-in ...
    5-15-2013
  • E&Y: Biotechs Must Walk the Walk on Drug Value
    ... Gilead, Glaxo, Janssen, Merck, Mitsubishi Tanabe, Novartis , Pfizer, and Sanofi-in ... Pharma venture funds and other sources have begun filling the gap left when VCs ...
    4-22-2013
  • Type 2 Diabetes Drugs Drive Sector Growth
    ... Wong says. In the U.S. market, Johnson & Johnson/Mitsubishi Tanabe Pharma's canagliflozin probably will be first to launch. "The clinical trials data look quite similar," he adds. ...
    2-1-2013
  • Next-Generation Plant Growth
    virus-like particles (VLPs), has worked with Mitsubishi before : in March, Mitsubishi Tanabe Pharma paid them C$3 million (around $2.97 million) up-front in a vaccine research ...
    1-28-2013
  • New Biotech Company Battles High Cholesterol
    Dezima Pharma in-licensed a cholesteryl ester transfer protein (CETP) inhibitor DEZ-001 (formerly TA-8995) from Mitsubishi Tanabe Pharma. Founded in 2012 and seed-financed by ...
    1-22-2013
  • Partnering Across the Pacific
    ... Among Japanese companies, Kyorin Pharmaceutical and Meiji Seika Kaisha of Tokyo, Kissei Pharmaceutical of Matsumoto City, and Mitsubishi Tanabe Pharma of Osaka are among the ...
    12-10-2012
  • 25 Diabetes Drugs in the Pipeline Right Now
    ... Johnson & Johnson (Janssen Research & Development); licensed from Mitsubishi Tanabe Pharma Mechanism of action: SGLT2 inhibitor Indication (Phase): U.S. -Once-daily oral ...
    11-30-2012
  • Firms Partner on Bispecific Fynomer Therapeutics
    Mitsubishi Tanabe Pharma is paying Swiss firm Covagen €4 million (about $5.2 million) up front as part of a research collaboration and license agreement focused on exploiting ...
    10-17-2012
  • Tobacco Giant Strikes Flu Vaccine Deal
    During early spring this year Medicago established a strategic alliance with Mitsubishi Pharma Tanabe to establish joint development programs for at least three new vaccines, ...
    9-25-2012
  • OncoEthix Gains Rights to Mitsubishi Tanabe's Anticancer Bromodomain...
    Swiss cancer drug developer OncoEthix negotiated a license to Mitsubishi Tanabe Pharma's bromodomain inhibitor OTX015. The synthetic small molecule targets BET bromodomains 2, 3, ...
    6-15-2012
  • Firms Report Phase III Data at 72nd American Diabetes Association...
    ... The firm licensed rights to the drug in territories including North America and Europe from Mitsubishi Tanabe Pharma. Multiple regulatory filings are planned this year from firms ...
    6-11-2012
  • Nuron Gains Preclinical Alzheimer Vaccine from Vitruvian BioMedical
    It subsequently gave Mitsubishi Tanabe Pharma Japanese rights. HibTiter is a glycoconjugate technology vaccine on the market for reducing the incidence of Hib disease in children. ...
    4-9-2012

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll